Feature

Video

AstraZeneca Vice President, Head of Breast Cancer Franchise, Discusses Impact of Truqap Approval

Author(s):

Don Tracy, Associate Editor

In an interview with Pharmaceutical Executive associate editor Don Tracy, Ashley Gaines, VP, head of breast cancer franchise, discusses newly approved Truqap.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Related Content
FDA Approves Ionis Pharmaceuticals’ Dawnzera for Hereditary Angioedema
August 22nd 2025

FDA Approves Ionis Pharmaceuticals’ Dawnzera for Hereditary Angioedema

Don Tracy, Associate Editor
Peter Ax, UpScriptHealth
August 22nd 2025

Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals

Miranda Schmalfuhs
Alan Crowther
August 22nd 2025

What the Most Favored Nation Executive Order Means to Pharma Brands and Future Implications

Mike Hollan
Navigating Distrust: Pharma in the Age of Social Media
August 22nd 2025

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
FDA Approves Tonix Pharmaceuticals’ Tonmya for Fibromyalgia
August 22nd 2025

FDA Approves Tonix Pharmaceuticals’ Tonmya for Fibromyalgia

Don Tracy, Associate Editor
Novo Nordisk’s Stock Price Soars Following Accelerated Approval of Wegovy for MASH and Liver Fibrosis
August 22nd 2025

Novo Nordisk’s Stock Price Soars Following Accelerated Approval of Wegovy for MASH and Liver Fibrosis

Don Tracy, Associate Editor